"Bacterial Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease.
Descriptor ID |
D001428
|
MeSH Number(s) |
D20.215.894.135
|
Concept/Terms |
Bacterial Vaccines- Bacterial Vaccines
- Vaccine, Bacterial
- Bacterin
- Bacterial Vaccine
- Vaccines, Bacterial
|
Below are MeSH descriptors whose meaning is more general than "Bacterial Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Bacterial Vaccines".
This graph shows the total number of publications written about "Bacterial Vaccines" by people in this website by year, and whether "Bacterial Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
1995 | 3 | 1 | 4 |
1996 | 4 | 0 | 4 |
1997 | 3 | 2 | 5 |
1998 | 7 | 1 | 8 |
1999 | 6 | 2 | 8 |
2000 | 1 | 0 | 1 |
2001 | 1 | 1 | 2 |
2002 | 0 | 1 | 1 |
2003 | 1 | 0 | 1 |
2004 | 0 | 2 | 2 |
2005 | 1 | 1 | 2 |
2007 | 2 | 1 | 3 |
2008 | 1 | 2 | 3 |
2009 | 1 | 1 | 2 |
2011 | 1 | 0 | 1 |
2012 | 1 | 0 | 1 |
2014 | 0 | 2 | 2 |
2015 | 1 | 0 | 1 |
2017 | 1 | 1 | 2 |
2018 | 1 | 0 | 1 |
2020 | 1 | 0 | 1 |
2021 | 0 | 1 | 1 |
2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bacterial Vaccines" by people in Profiles.
-
Revolution of Helicobacter pylori treatment. J Gastroenterol Hepatol. 2024 Jun; 39(6):1016-1026.
-
Helicobacter pylori. Curr Top Microbiol Immunol. 2024; 445:127-154.
-
Identification of vaccine targets in pathogens and design of a vaccine using computational approaches. Sci Rep. 2021 09 02; 11(1):17626.
-
Structural basis and designing of peptide vaccine using PE-PGRS family protein of Mycobacterium ulcerans-An integrated vaccinomics approach. Mol Immunol. 2020 04; 120:146-163.
-
Efficacy, immunogenicity, and safety of a parenteral vaccine against Helicobacter pylori in healthy volunteers challenged with a Cag-positive strain: a randomised, placebo-controlled phase 1/2 study. Lancet Gastroenterol Hepatol. 2018 10; 3(10):698-707.
-
Genome and Methylome Variation in Helicobacter pylori With a cag Pathogenicity Island During Early Stages of Human Infection. Gastroenterology. 2018 02; 154(3):612-623.e7.
-
Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial. Vaccine. 2017 08 24; 35(36):4730-4737.
-
Immunization of bighorn sheep against Mannheimia haemolytica with a bovine herpesvirus 1-vectored vaccine. Vaccine. 2017 03 14; 35(12):1630-1636.
-
A chimeric protein comprising the immunogenic domains of Mannheimia haemolytica leukotoxin and outer membrane protein PlpE induces antibodies against leukotoxin and PlpE. Vet Immunol Immunopathol. 2016 Jul; 175:36-41.
-
Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliC. Emerg Microbes Infect. 2016 Feb 03; 5:e8.